Assembly Biosciences, Inc.
ASMB
$36.10
$0.220.61%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.20M | -10.20M | -8.82M | -10.34M | -9.61M |
| Total Depreciation and Amortization | 32.00K | 32.00K | 33.00K | 32.00K | 33.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.25M | 674.00K | 423.00K | 511.00K | 307.00K |
| Change in Net Operating Assets | -7.22M | -7.27M | -15.08M | 9.39M | -5.97M |
| Cash from Operations | -15.13M | -16.76M | -23.44M | -407.00K | -15.24M |
| Capital Expenditure | -42.00K | -- | -- | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -158.23M | 16.99M | 6.59M | -6.70M | 24.49M |
| Cash from Investing | -158.27M | 16.99M | 6.59M | -6.70M | 24.49M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 171.93M | 357.00K | 1.92M | 17.00M | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 171.93M | 357.00K | 1.92M | 17.00M | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.47M | 593.00K | -14.93M | 9.89M | 9.24M |